J&J Study?, page-8

There is no transparancy at all! How is the J&J study evolving? Are all participants enrolled, what are the primary and secondary endpoints? Is the company going for FDA approval for only rotator cuff or other tendon problems as well? Why all these little studies? What's the use of them? Why not a single progression in capital markets like China, Japan although there is so much experience in the board of directors? Cash is a big problem: they should raise 100m AUD to be financial strong. Why doesn't the company ask to be listed on the Nasdaq to get more attention internationally? Before there will be a substantial rise in share price, if that would happen (maybe after FDA approval of celgro AND ortho-ATI), all the warrants need to be converted. That is a BIG barrier to overcome, just look it up, you'll be negatively surprised I ask for five things: transparancy, capital raise, reverse split after the capital raise, listing on Nasdaq, and Finally execution of penetration in the Japanese and Chinese market.